Ginkgo biloba extract decreases non-small cell lung cancer cell migration by downregulating metastasis-associated factor heat-shock protein 27

PLoS ONE

Volumn 9, Issue 3, 2014, Pages

  Tsai, Jong Rung ^a,b   Liu, Po Len ^a   Chen, Yung Hsiang ^c   Chou, Shah Hwa ^a,b   Yang, Ming Chan ^d   Cheng, Yu Jen ^e   Hwang, Jhi Jhu ^a,b   Yin, Wei Hsian ^f   Chong, Inn Wen ^a,b  

^a KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^c CHINA MEDICAL UNIVERSITY   (Taiwan)

^d YUAN'S GENERAL HOSPITAL   (Taiwan)

^e I SHOU UNIVERSITY   (Taiwan)

^f NATIONAL YANG MING UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

GINKGO BILOBA EXTRACT; HEAT SHOCK PROTEIN 27; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; MITOGEN ACTIVATED PROTEIN KINASE 14; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; SYNAPTOPHYSIN; ANTINEOPLASTIC AGENT; GINKGO BILOBA EXTRACT 761; MITOGEN ACTIVATED PROTEIN KINASE P38; PLANT EXTRACT;

ADULT; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INHIBITION; CANCER PROGNOSIS; CANCER SURVIVAL; CELL MIGRATION; CONCENTRATION RESPONSE; CONTROLLED STUDY; DOWN REGULATION; DRUG CYTOTOXICITY; DRUG EFFECT; ENZYME ACTIVATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; SURVIVAL TIME; WESTERN BLOTTING; CANCER STAGING; CELL MOTION; CHEMISTRY; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GINKGO BILOBA; LUNG TUMOR; METABOLISM; METASTASIS; MIDDLE AGED; MORTALITY; NON SMALL CELL LUNG CANCER; PATHOLOGY; RNA INTERFERENCE; TUMOR CELL LINE;

ADULT; AGED; ANTINEOPLASTIC AGENTS, PHYTOGENIC; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL MOVEMENT; DOWN-REGULATION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GINKGO BILOBA; HSP27 HEAT-SHOCK PROTEINS; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASM STAGING; P38 MITOGEN-ACTIVATED PROTEIN KINASES; PLANT EXTRACTS; PROTO-ONCOGENE PROTEINS C-AKT; RNA INTERFERENCE; SIGNAL TRANSDUCTION;

EID: 84897493639     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0091331     Document Type: Article

References (59)

1. Rozsas A, Berta J, Rojko L, Horvath LZ, Keszthelyi M, et al. (2013) Erythropoietin receptor expression is a potential prognostic factor in human lung adenocarcinoma. PLoS One 8: e77459.
2. Chen X, Liu Y, Roe OD, Qian Y, Guo R, et al. (2013) Gefitinib or erlotinib as maintenance therapy in patients with advanced stage non-small cell lung cancer: a systematic review. PLoS One 8: e59314.
3. Gandour-Edwards R, Trock BJ, Gumerlock P, Donald PJ (1998) Heat shock protein and p53 expression in head and neck squamous cell carcinoma. Otolaryngol Head Neck Surg 118: 610-615. (Pubitemid 28222202)
4. Ciocca DR, Calderwood SK (2005) Heat shock proteins in cancer: diagnostic, prognostic, predictive, and treatment implications. Cell Stress Chaperones 10: 86-103. (Pubitemid 40942470)
5. Erkizan O, Kirkali G, Yorukoglu K, Kirkali Z (2004) Significance of heat shock protein-27 expression in patients with renal cell carcinoma. Urology 64: 474-478. (Pubitemid 39200740)
6. Eskenazi AE, Powers J, Pinkas J, Oesterreich S, Fuqua SA, et al. (1998) Induction of heat shock protein 27 by hydroxyurea and its relationship to experimental metastasis. Clin Exp Metastasis 16: 283-290. (Pubitemid 28201996)
7. Moon A, Bacchini P, Bertoni F, Olvi LG, Santini-Araujo E, et al. (2010) Expression of heat shock proteins in osteosarcomas. Pathology 42: 421-425.
8. Bausero MA, Page DT, Osinaga E, Asea A (2004) Surface expression of Hsp25 and Hsp72 differentially regulates tumor growth and metastasis. Tumour Biol 25: 243-251. (Pubitemid 40082326)
9. Conroy SE, Sasieni PD, Amin V, Wang DY, Smith P, et al. (1998) Antibodies to heat-shock protein 27 are associated with improved survival in patients with breast cancer. Br J Cancer 77: 1875-1879. (Pubitemid 28254627)
10. Hsu HS, Lin JH, Huang WC, Hsu TW, Su K, et al. (2011) Chemoresistance of lung cancer stemlike cells depends on activation of Hsp27. Cancer.
11. Arts HJ, Hollema H, Lemstra W, Willemse PH, De Vries EG, et al. (1999) Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma: relation in response to chemotherapy and prognosis. Int J Cancer 84: 234-238. (Pubitemid 29256747)
12. Lemieux P, Oesterreich S, Lawrence JA, Steeg PS, Hilsenbeck SG, et al. (1997) The small heat shock protein hsp27 increases invasiveness but decreases motility of breast cancer cells. Invasion Metastasis 17: 113-123. (Pubitemid 28379685)
13. Kapranos N, Kominea A, Konstantinopoulos PA, Savva S, Artelaris S, et al. (2002) Expression of the 27-kDa heat shock protein (HSP27) in gastric carcinomas and adjacent normal, metaplastic, and dysplastic gastric mucosa, and its prognostic significance. J Cancer Res Clin Oncol 128: 426-432. (Pubitemid 35007553)
14. Takeno S, Noguchi T, Kikuchi R, Sato T, Uchida Y, et al. (2001) Analysis of the survival period in resectable stage IV gastric cancer. Ann Surg Oncol 8: 215-221. (Pubitemid 32294801)
15. King KL, Li AF, Chau GY, Chi CW, Wu CW, et al. (2000) Prognostic significance of heat shock protein-27 expression in hepatocellular carcinoma and its relation to histologic grading and survival. Cancer 88: 2464-2470. (Pubitemid 30331951)
16. Cornford PA, Dodson AR, Parsons KF, Desmond AD, Woolfenden A, et al. (2000) Heat shock protein expression independently predicts clinical outcome in prostate cancer. Cancer Res 60: 7099-7105. (Pubitemid 32059190)
17. Atkins D, Lichtenfels R, Seliger B (2005) Heat shock proteins in renal cell carcinomas. Contrib Nephrol 148: 35-56. (Pubitemid 43264921)
18. Zimmermann M, Nickl S, Lambers C, Hacker S, Mitterbauer A, et al. (2012) Discrimination of clinical stages in non-small cell lung cancer patients by serum HSP27 and HSP70: a multi-institutional case-control study. Clin Chim Acta 413: 1115-1120.
19. Berrieman HK, Cawkwell L, O'Kane SL, Smith L, Lind MJ (2006) Hsp27 may allow prediction of the response to single-agent vinorelbine chemotherapy in non-small cell lung cancer. Oncol Rep 15: 283-286.
20. Malusecka E, Krzyzowska-Gruca S, Gawrychowski J, Fiszer-Kierzkowska A, Kolosza Z, et al. (2008) Stress proteins HSP27 and HSP70i predict survival in non-small cell lung carcinoma. Anticancer Res 28: 501-506. (Pubitemid 351362860)
21. Wang W, Xu X, Wang W, Shao W, Li L, et al. (2011) The expression and clinical significance of CLIC1 and HSP27 in lung adenocarcinoma. Tumour Biol 32: 1199-1208.
22. Pietri S, Seguin JR, d'Arbigny P, Drieu K, Culcasi M (1997) Ginkgo biloba extract (EGb 761) pretreatment limits free radical-induced oxidative stress in patients undergoing coronary bypass surgery. Cardiovasc Drugs Ther 11: 121-131. (Pubitemid 27153545)
23. Chao JC, Chu CC (2004) Effects of Ginkgo biloba extract on cell proliferation and cytotoxicity in human hepatocellular carcinoma cells. World J Gastroenterol 10: 37-41. (Pubitemid 38071974)
24. DeFeudis FV, Papadopoulos V, Drieu K (2003) Ginkgo biloba extracts and cancer: a research area in its infancy. Fundam Clin Pharmacol 17: 405-417. (Pubitemid 36920641)
25. Onen A, Deveci E, Inaloz SS, Isik B, Kilinc M (1999) Histopathological assessment of the prophylactic effect of gingko-biloba extract on intestinal ischemia-reperfusion injury. Acta Gastroenterol Belg 62: 386-389. (Pubitemid 30075364)
26. Oken BS, Storzbach DM, Kaye JA (1998) The efficacy of Ginkgo biloba on cognitive function in Alzheimer disease. Arch Neurol 55: 1409-1415. (Pubitemid 28525500)
27. Chen XH, Miao YX, Wang XJ, Yu Z, Geng MY, et al. (2011) Effects of Ginkgo biloba extract EGb761 on human colon adenocarcinoma cells. Cell Physiol Biochem 27: 227-232.
28. Kim KS, Rhee KH, Yoon JH, Lee JG, Lee JH, et al. (2005) Ginkgo biloba extract (EGb 761) induces apoptosis by the activation of caspase-3 in oral cavity cancer cells. Oral Oncol 41: 383-389. (Pubitemid 40387867)
29. Hauns B, Haring B, Kohler S, Mross K, Robben-Bathe P, et al. (1999) Phase II study with 5-fluorouracil and ginkgo biloba extract (GBE 761 ONC) in patients with pancreatic cancer. Arzneimittelforschung 49: 1030-1034. (Pubitemid 30013113)
30. Nano M, Lanfranco G, Dal Corso H, Ferronato M, Solej M (2000) The lateral ligaments of the rectum: myth or reality? Chir Ital 52: 313-321.
31. Wang G, Reed E, Li QQ (2004) Molecular basis of cellular response to cisplatin chemotherapy in non-small cell lung cancer (Review). Oncol Rep 12: 955-965.
32. Grabinski N, Bartkowiak K, Grupp K, Brandt B, Pantel K, et al. (2011) Distinct functional roles of Akt isoforms for proliferation, survival, migration and EGF-mediated signalling in lung cancer derived disseminated tumor cells. Cell Signal.
33. Mansi L, Viel E, Curtit E, Medioni J, Le Tourneau C (2011) Targeting the RAS signalling pathway in cancer. Bull Cancer.
34. Hightower LE (1991) Heat shock, stress proteins, chaperones, and proteotoxicity. Cell 66: 191-197.
35. Aldrian S, Trautinger F, Frohlich I, Berger W, Micksche M, et al. (2002) Overexpression of Hsp27 affects the metastatic phenotype of human melanoma cells in vitro. Cell Stress Chaperones 7: 177-185. (Pubitemid 36133468)
36. Storm FK, Mahvi DM, Gilchrist KW (1996) Heat shock protein 27 overexpression in breast cancer lymph node metastasis. Ann Surg Oncol 3: 570-573. (Pubitemid 126729008)
37. Tsuruta M, Nishibori H, Hasegawa H, Ishii Y, Endo T, et al. (2008) Heat shock protein 27, a novel regulator of 5-fluorouracil resistance in colon cancer. Oncol Rep 20: 1165-1172.
38. Soldes OS, Kuick RD, Thompson IA 2nd, Hughes SJ, Orringer MB, et al. (1999) Differential expression of Hsp27 in normal oesophagus, Barrett's metaplasia and oesophageal adenocarcinomas. Br J Cancer 79: 595-603.
39. Kanitakis J, Zambruno G, Viac J, Tommaselli L, Thivolet J (1989) Expression of an estrogen receptor-associated protein (p29) in epithelial tumors of the skin. J Cutan Pathol 16: 272-276. (Pubitemid 19270242)
40. Ciocca DR, Puy LA, Fasoli LC (1989) Study of estrogen receptor, progesterone receptor, and the estrogen-regulated Mr 24,000 protein in patients with carcinomas of the endometrium and cervix. Cancer Res 49: 4298-4304. (Pubitemid 19207276)
41. Puy LA, Lo Castro G, Olcese JE, Lotfi HO, Brandi HR, et al. (1989) Analysis of a 24-kilodalton (KD) protein in the human uterine cervix during abnormal growth. Cancer 64: 1067-1073. (Pubitemid 19208860)
42. Bubendorf L, Kolmer M, Kononen J, Koivisto P, Mousses S, et al. (1999) Hormone therapy failure in human prostate cancer: analysis by complementary DNA and tissue microarrays. J Natl Cancer Inst 91: 1758-1764. (Pubitemid 29518772)
43. Takeno S, Noguchi T, Takahashi Y, Kikuchi R, Uchida Y, et al. (2001) Immunohistochemical and clinicopathologic analysis of response to neoadjuvant therapy for esophageal squamous cell carcinoma. Dis Esophagus 14: 149-154. (Pubitemid 32951987)
44. Hadchity E, Aloy MT, Paulin C, Armandy E, Watkin E, et al. (2009) Heat shock protein 27 as a new therapeutic target for radiation sensitization of head and neck squamous cell carcinoma. Mol Ther 17: 1387-1394.
45. Yao H, Zhang Z, Xiao Z, Chen Y, Li C, et al. (2009) Identification of metastasis associated proteins in human lung squamous carcinoma using two-dimensional difference gel electrophoresis and laser capture microdissection. Lung Cancer 65: 41-48.
46. Tian T, Hao J, Xu A, Hao J, Luo C, et al. (2007) Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis. Cancer Sci 98: 1265-1274. (Pubitemid 46993548)
47. Fukaya H, Kanno H (1999) [Experimental studies of the protective effect of ginkgo biloba extract (GBE) on cisplatin-induced toxicity in rats]. Nihon Jibiinkoka Gakkai Kaiho 102: 907-917.
48. Bao S, Wu Q, McLendon RE, Hao Y, Shi Q, et al. (2006) Glioma stem cells promote radioresistance by preferential activation of the DNA damage response. Nature 444: 756-760. (Pubitemid 44949604)
49. Dorion S, Landry J (2002) Activation of the mitogen-activated protein kinase pathways by heat shock. Cell Stress Chaperones 7: 200-206. (Pubitemid 36133471)
50. Chretien P, Landry J (1988) Enhanced constitutive expression of the 27-kDa heat shock proteins in heat-resistant variants from Chinese hamster cells. J Cell Physiol 137: 157-166.
51. Xia Z, Dickens M, Raingeaud J, Davis RJ, Greenberg ME (1995) Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis. Science 270: 1326-1331.
52. Zhang Y, Shen X (2007) Heat shock protein 27 protects L929 cells from cisplatin-induced apoptosis by enhancing Akt activation and abating suppression of thioredoxin reductase activity. Clin Cancer Res 13: 2855-2864. (Pubitemid 46849558)
53. Guo YL, Baysal K, Kang B, Yang LJ, Williamson JR (1998) Correlation between sustained c-Jun N-terminal protein kinase activation and apoptosis induced by tumor necrosis factor-alpha in rat mesangial cells. J Biol Chem 273: 4027-4034. (Pubitemid 28103267)
54. Ghosh A, Lai C, McDonald S, Suraweera N, Sengupta N, et al. (2012) HSP27 expression in primary colorectal cancers is dependent on mutation of KRAS and PI3K/AKT activation status and is independent of TP53. Exp Mol Pathol 94: 103-108.
55. Mountain CF (1997) Revisions in the International System for Staging Lung Cancer. Chest 111: 1710-1717.
56. Sarhadi VK, Wikman H, Salmenkivi K, Kuosma E, Sioris T, et al. (2006) Increased expression of high mobility group A proteins in lung cancer. J Pathol 209: 206-212. (Pubitemid 43805416)
57. Wikman H, Kettunen E, Seppanen JK, Karjalainen A, Hollmen J, et al. (2002) Identification of differentially expressed genes in pulmonary adenocarcinoma by using cDNA array. Oncogene 21: 5804-5813. (Pubitemid 35333015)
58. Weiss A, Wiskocil RL, Stobo JD (1984) The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol 133: 123-128. (Pubitemid 14076697)
59. Tang S, Morgan KG, Parker C, Ware JA (1997) Requirement for protein kinase C theta for cell cycle progression and formation of actin stress fibers and filopodia in vascular endothelial cells. J Biol Chem 272: 28704-28711. (Pubitemid 27517827)